Over the weekend, President Donald Trump’s executive order restricting travel from specific countries went into effect, leaving many Biotech executives wondering about the free travel of their employees. Xencor CEO, Bassil Dahiyat commented, “We are one of many companies made up of a large percentage of immigrant staff, highly talented and trained. We cease to function without immigrants, period.” Many pharmaceutical companies have denied commenting on the issue. Read the full article here.
